Lonza Announces Global Seminar Series on Quality Control Microbiology Automation Featuring MODA™ Solution

Share Article

6-city tour to include implementation successes across life sciences industry

Lonza will offer complimentary, full-day seminars in six cities across the West Coast United States and Western & Central Europe on the automation advancements of Quality Control Microbiology (QC Micro), featuring the MODA™ Solution, in the following cities:

West Coast United States: Monday, March 21: San Diego, CA; Wednesday, March 23: Los Angeles, CA; and Thursday, March 24: San Francisco, CA.

Western & Central Europe: Monday, April 4: Paris, FR; Wednesday, April 6: Frankfurt, DE; and Thursday, April 7: London, UK.

Each seminar will run 10:00 AM to 4:00 PM and includes lunch and an international coffee reception. These full-day seminars will provide unique opportunities to:

  • See hands-on demos of the MODA™ Solution (Data capture, lab processing, reports and analytics)
  • Hear QC Micro Automation successes implemented across the life sciences industry
  • Participate in interactive presentations and peer networking

In addition to customer presentations, the seminars will feature keynote speakers who are influential voices within the life sciences industry. Attendees of the West Coast United States seminars will hear from Scott Sutton, Ph.D., founder of Microbiology Network, Inc. Attendees of the Western and Central Europe seminars will hear from Karen S. Ginsbury, president of Pharmaceutical Consulting Israel Ltd and member of PDA's microbiological task force.

The seminars will be co-sponsored by heipha GmbH who will present their pre-barcoded media plates that integrate with the MODA Solution. Other laboratory and cleanroom integration technologies will also be demonstrated.

To view the full agenda and to register for the city nearest you, visit http://www.lonza.com/MODAevent

Paper-based processes still burden most QC Micro programs: paper scheduling, sharpie pen labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. These seminars will demonstrate QC Automation best practices that a growing number of Pharmaceutical and Biotechnology companies are implementing across their manufacturing facilities.

About MODA™ Solution
More science. Less paper.™ The MODA™ solution strengthens Lonza's overall Rapid Testing Solutions platform by adding a complementary product offering for quality assurance (QA) and quality control (QC) organizations in the life science industry. The MODA™ solution offers automated data collection, workflow management, on demand analytics and visualization of regulated manufacturing processes, including environmental monitoring (EM), utility testing, and product testing. The MODA™ solution eliminates inefficiencies and reduces error rates inherent with paper-based systems. Further information can be found at http://www.lonza.com/moda

About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers' needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2010, the company had sales of CHF 2.680 billion. Further information can be found at http://www.lonza.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bob Toal
Rapid Testing Solutions
1-484-253-1000 ext. 133
Email >

Melanie Disa
External Communications
1-201-316-9413
Email >